Skip to content

Mimedic: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

Mimedic

BE 0798.707.205
NACE division all sizesfiscal years 2023 to 2024

The register lists no main activity for this company, so there is no sector to compare with. Below are the company's own ratios.

Solvency and debt

How soundly the company is financed.
Solvency
95.3%▲2024

No sector comparison available for this ratio.

No sector comparison for this ratio.

20232024
Debt to equity
0.05▼2024

No sector comparison available for this ratio.

No sector comparison for this ratio.

20232024
Interest coverage
942.562024

No sector comparison available for this ratio.

No sector comparison for this ratio.

20232024

Liquidity

Whether it can pay its short-term bills.
Current ratio
20.33▲2024

No sector comparison available for this ratio.

No sector comparison for this ratio.

20232024
Working-capital ratio
91.6%▲2024

No sector comparison available for this ratio.

No sector comparison for this ratio.

20232024

Profitability

What the company earns on its assets and its sales.
Return on equity
37.1%▼2024

No sector comparison available for this ratio.

No sector comparison for this ratio.

20232024
Return on assets
35.3%▼2024

No sector comparison available for this ratio.

No sector comparison for this ratio.

20232024

Not computable

Long-term debt ratio, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. The filed figures do not contain the lines these need.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.